Background Detecting cancer at an early stage before clinical manifestation could be an effective strategy to decrease cancer mortality. Thus, identifying liquid biopsy biomarkers with high efficacy could be a promising approach for non-invasive diagnosis of cancer. Main text Liquid biopsies are increasingly used as a supplement to biopsy, as it enables disease progression to be detected months before clinical and radiographic confirmation. Many bodily fluids contain exosomal microRNAs (miRNAs) which could provide a new class of biomarkers for early and minimally invasive cancer diagnosis due to the stability of miRNAs in exosomes. In this review, we mainly focused on the exosomal miRNAs (liquid biopsy) as biomarkers in the diagnosis and prognosis of various cancers. Conclusion Exosomal miRNAs can be used as diagnostic and prognosis biomarkers that provide unique insights and a more dynamic perspective of the progression and therapeutic responses in various malignancies. Therefore, the development of novel and more sensitive technologies that exploit exosomal miRNAs should be a priority for cancer management.

Background Cancer is caused by a combination of genetic and epigenetic abnormalities. Current cancer therapies are limited due to the complexity of their mechanism, underlining the need for alternative therapeutic approaches. Interestingly, combining the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) system with next-generation sequencing (NGS) has the potential to speed up the identification, validation, and targeting of high-value targets. Main text Personalized or precision medicine combines genetic information with phenotypic and environmental characteristics to produce healthcare tailored to the individual and eliminates the constraints of “one-size-fits-all” therapy. Precision medicine is now possible thanks to cancer genome sequencing. Having advantages over limited sample requirements and the recent development of biomarkers have made the use of NGS a major leap in personalized medicine. Tumor and cell-free DNA profiling using NGS, proteome and RNA analyses, and a better understanding of immunological systems, are all helping to improve cancer treatment choices. Finally, direct targeting of tumor genes in cancer cells with CRISPR/Cas9 may be achievable, allowing for eliminating genetic changes that lead to tumor growth and metastatic capability. Conclusion With NGS and CRISPR/Cas9, the goal is no longer to match the treatment for the diagnosed tumor but rather to build a treatment method that fits the tumor exactly. Hence, in this review, we have discussed the potential role of CRISPR/Cas9 and NGS in advancing personalized medicine.

Food safety and health conditions are global issues that are primarily caused by insufficient nutrition or contaminated food, which have enormous social, economic, and public health implications. Foodomics study mainly involves nutrigenomics, nutrigenetics, and nutritional epigenetics, which help in finding the correlation between genetic variation and nutrient‐driven epigenetic alterations that are suggested as a primary challenge to nutritional needs. Micro‐ribonucleic acids (miRNAs) are non‐coding RNA molecules that have recently gained in popularity as a result of their critical roles in gene regulation and nutritional studies. In this commentary, the relevance of miRNAs to human nutrition is discussed. This study emphasizes the importance of dietary miRNAs based on numerous independent studies, which have explained the unique characteristics of dietary miRNAs in terms of gene expression regulation mechanism. There is an urgent requirement of measurement techniques to detect miRNA in food and evolutionary samples. These techniques may be helpful to find even low levels of miRNAs because of their high susceptibility and selectivity. There is a desperate requisite to evaluate the impact of dietary supplement compounds on circulating and tissue miRNAs. Food science studies in humans may aid in the identification of novel biomarkers and other necessary mode of action of certain dietary compounds, with the goal of facilitating how nutrients and bioactive components can influence miRNAs and enforce biological effects. Practical applications Dietary microRNAs may be helpful to find even the low levels of miRNAs due to their high susceptibility and selectivity. There is also desperate need to evaluate the impact of dietary supplement compounds effect on circulating and tissue miRNAs. There is also requirement for new analytical tools to study the role of gene regulations and nutrition in different diseases. The quality of dietary miRNAs should be investigated, particularly the exogenous types which are used as high doses in food supplements. It would also be of great interest to use antagomir technology in food science research, in addition to omics technology. Dietary miRNAs may also aid in the identification of novel biomarkers. These are some of the practical applications of dietary miRNAs.

No abstract

No abstract

No abstract

No abstract

No abstract